Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?
February 1, 2013|
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.